Introduction: We hypothesized that immune-mediated events rather than direct toxin injury might be involved in the pathogenesis of HUS associated with shiga-like toxin (SLT) producing E. coli. Purposes: Our objectives were to learn whether antibodies (AB) exist to the SLT glycolipid receptor Gb3, to define the occurrence and relationship between such anti-Gb3 ABs (α-Gb3) and anti-idiotypic ABs to them (α-α-Gb3), and to evaluate children infected with E. coli O157:H7 for these ABs.Methods: ELISAs were used for detecting α-Gb3 orα-α-Gb3 in sera from normal adults [n=15] and from children with E. coli O157:H7 associated with [n=24] or without [n=38] development of HUS. Results: Normals have both α-Gb3 and α-α-Gb3; levels of these ABs are correlated [r=0.9654]. The relationship between these antibodies in E. coli O157:H7 infection is shown below: Table Conclusions:(1) Autoantibodies to Gb3 are normally found. (2) α-Gb3 exists in balance with α-α-Gb3. (3) Children with HUS during the acute phase have significantly decreased levels of these ABs. We hypothesize that these ABs are low because α-α-Gb3 binds to SLT leaving α-Gb3 available to bind to Gb3 of endothelial cells and induce vascular injury. [Supported in part by NIH-PO1 HD-13021]

Table 1